Skip to content
★ Sign in to follow
CB

Carl Bjartmar

Wilson Therapeutics AB
Total declarations
2
Company
1
▲ Purchases (1 ops.)
€22k
▼ Sales (1 ops.)
€79k

Latest filing published 27 May 2018 for Wilson Therapeutics AB, €79k.

Filing timeline

BuySale
Carl Bjartmar

Insider track record

Disclosed buys
1
Disclosed sells
1
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Carl Bjartmar: trading record in brief

This profile gathers the share dealings of Carl Bjartmar in Wilson Therapeutics AB. The record holds 2 filings, for trades running from 2 September 2016 to 25 May 2018.

Market trades split into 1 purchase (€22k) and 1 sale (€79k). Netting one side against the other leaves €57k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2018 to date brings no purchases and 1 sale.

The latest filing, published on 27 May 2018, reports an open-market sale of €79k in Wilson Therapeutics AB. The latest purchase dates back some time: it was published 3,719 days ago, on 2 September 2016. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Carl Bjartmar

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▼
    CMOExecutivesWilson Therapeutics AB
    812,000 SEK37FI-SE
    3,500 shares@ SEK 232.0078.6% of flowISIN SE0008293674FI:csv-d9a80cbe4f1d3be25f4a
  • ▲
    CMOExecutivesWilson Therapeutics AB
    206,675 SEK25FI-SE
    3,500 shares@ SEK 59.0521.4% of flowISIN SE0008293674FI:csv-c1b1334578498d901e74
    Canonical exit: 1 Dec 2016 (T+90)

2 of 2 declarations